{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:19:24Z","timestamp":1770358764495,"version":"3.49.0"},"reference-count":23,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["HO-15-15223"],"award-info":[{"award-number":["HO-15-15223"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1111\/ijcp.12833","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T05:32:41Z","timestamp":1468215161000},"page":"676-681","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and burden of dyspnoea among COPD patients in Japan"],"prefix":"10.1155","volume":"70","author":[{"given":"M.","family":"Small","sequence":"first","affiliation":[{"name":"Adelphi Real World; Macclesfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Holbrook","sequence":"additional","affiliation":[{"name":"Adelphi Real World; Macclesfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wood","sequence":"additional","affiliation":[{"name":"Adelphi Real World; Macclesfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mullerova","sequence":"additional","affiliation":[{"name":"Worldwide Epidemiology; GlaxoSmithKline R&D; Uxbridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Naya","sequence":"additional","affiliation":[{"name":"Respiratory Medical; GlaxoSmithKline; Brentford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-1319","authenticated-orcid":false,"given":"Y. S.","family":"Punekar","sequence":"additional","affiliation":[{"name":"Value Evidence and Outcomes; GlaxoSmithKline R&D; Brentford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"10.1111\/ijcp.12833-BIB0001|ijcp12833-cit-0001","unstructured":"World Health Report Geneva World Health Organisation http:\/\/www.who.int\/whr\/2000\/en\/"},{"issue":"10","key":"10.1111\/ijcp.12833-BIB0002|ijcp12833-cit-0002","first-page":"1721","article-title":"Epidemiology of COPD in Japan","volume":"69","author":"Minakata","year":"2011","journal-title":"Nihon Rinsho"},{"key":"10.1111\/ijcp.12833-BIB0003|ijcp12833-cit-0003","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1183\/09031936.00051110","article-title":"Symptom variability in patients with severe COPD: a pan-European cross-sectional study","volume":"37","author":"Kessler","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1111\/ijcp.12833-BIB0004|ijcp12833-cit-0004","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.rmed.2005.10.006","article-title":"Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD","volume":"100","author":"Oga","year":"2006","journal-title":"Respir Med"},{"issue":"2","key":"10.1111\/ijcp.12833-BIB0005|ijcp12833-cit-0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006199-199903000-00004","article-title":"Adult emergency visits for chronic cardiorespiratory disease: does dyspnea matter?","volume":"48","author":"Parshall","year":"1999","journal-title":"Nurs Res"},{"issue":"3","key":"10.1111\/ijcp.12833-BIB0006|ijcp12833-cit-0006","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1183\/09031936.00195212","article-title":"Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort","volume":"42","author":"Agusti","year":"2013","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1111\/ijcp.12833-BIB0007|ijcp12833-cit-0007","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201207-1299OC","article-title":"Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of general population","volume":"186","author":"Lange","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/ijcp.12833-BIB0008|ijcp12833-cit-0008","unstructured":"http:\/\/www.exchangerates.org.uk\/JPY-EUR-exchange-rate-history.html"},{"issue":"3","key":"10.1111\/ijcp.12833-BIB0009|ijcp12833-cit-0009","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"10.1111\/ijcp.12833-BIB0010|ijcp12833-cit-0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1468-0262.2006.00655.x","article-title":"Large sample properties of matching estimators for average treatment effects","volume":"74","author":"Abadie","year":"2006","journal-title":"Econometrica"},{"issue":"1","key":"10.1111\/ijcp.12833-BIB0011|ijcp12833-cit-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1198\/jbes.2009.07333","article-title":"Bias-corrected matching estimators for average treatment effects","volume":"29","author":"Abadie","year":"2011","journal-title":"J Bus Econ Stat"},{"issue":"6","key":"10.1111\/ijcp.12833-BIB0012|ijcp12833-cit-0012","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3982\/ECTA6474","article-title":"On the failure of the bootstrap for matching estimators","volume":"76","author":"Abadie","year":"2008","journal-title":"Econometrica"},{"key":"10.1111\/ijcp.12833-BIB0013|ijcp12833-cit-0013","unstructured":"Abadie A Imbens G Matching on the Estimated Propensity Score http:\/\/www.hks.harvard.edu\/fs\/aabadie\/pscore.pdf"},{"key":"10.1111\/ijcp.12833-BIB0014|ijcp12833-cit-0014","first-page":"3551","volume-title":"Encyclopedia of Biostatistics","author":"Rosenbaum","year":"1998"},{"key":"10.1111\/ijcp.12833-BIB0015|ijcp12833-cit-0015","first-page":"597","article-title":"Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012-2013","volume":"9","author":"Landis","year":"2014","journal-title":"Int J COPD"},{"key":"10.1111\/ijcp.12833-BIB0016|ijcp12833-cit-0016","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00063198-200203000-00004","article-title":"Chronic obstructive pulmonary disease in Japan","volume":"8","author":"Izumi","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"10.1111\/ijcp.12833-BIB0017|ijcp12833-cit-0017","article-title":"Continuing to Confront COPD International Patient Survey: economic impact of COPD in 12 countries","volume":"11","author":"Foo","journal-title":"PLoS ONE"},{"issue":"S2","key":"10.1111\/ijcp.12833-BIB0018|ijcp12833-cit-0018","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0954-6111(12)70014-8","article-title":"The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study","volume":"106","author":"Uzaslan","year":"2012","journal-title":"Respir Med"},{"issue":"6","key":"10.1111\/ijcp.12833-BIB0019|ijcp12833-cit-0019","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1183\/09031936.00036813","article-title":"Predictors of dyspnea prevalence: results from the BOLD study","volume":"43","author":"Gr\u00f8nseth","year":"2014","journal-title":"Eur Respir J"},{"issue":"19","key":"10.1111\/ijcp.12833-BIB0020|ijcp12833-cit-0020","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1111\/ijcp.12833-BIB0021|ijcp12833-cit-0021","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/occmed\/kqm162","article-title":"The MMRC dyspnoea scale","volume":"58","author":"Stenton","year":"2008","journal-title":"Occup Med (Lond)"},{"issue":"14","key":"10.1111\/ijcp.12833-BIB0022|ijcp12833-cit-0022","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa1407154","article-title":"Withdrawal of inhaled glucocorticoids and exacerbations of COPD","volume":"371","author":"Magnussen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12833-BIB0023|ijcp12833-cit-0023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12931-015-0295-2","article-title":"Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care","volume":"16","author":"Punekar","year":"2015","journal-title":"Respir Res"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12833","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:09:39Z","timestamp":1643350179000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12833","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7,11]]}}}